Skip to main content
Erschienen in: Trials 1/2020

Open Access 17.06.2020 | COVID-19 | Correction

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

verfasst von: Christina M. Eckhardt, Matthew J. Cummings, Kartik N. Rajagopalan, Sarah Borden, Zachary C. Bitan, Allison Wolf, Alex Kantor, Thomas Briese, Benjamin J. Meyer, Samuel D. Jacobson, Dawn Scotto, Nischay Mishra, Neena M. Philip, Brie A. Stotler, Joseph Schwartz, Beth Shaz, Steven L. Spitalnik, Andrew Eisenberger, Eldad A. Hod, Jessica Justman, Ken Cheung, W. Ian Lipkin, Max R. O’Donnell

Erschienen in: Trials | Ausgabe 1/2020

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The original article can be found online at https://​doi.​org/​10.​1186/​s13063-020-04422-y.
Correction to: Trials 21, 499 (2020)
https://doi.org/10.1186/s13063-020-04422-y
Following publication of the original article [1], the authors identified an error in the author name of Andrew Eisenberger.
The incorrect author name is: Andrew Eisenberg
The correct author name is: Andrew Eisenberger
The author group has been updated above and the original article [1] has been corrected.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial
verfasst von
Christina M. Eckhardt
Matthew J. Cummings
Kartik N. Rajagopalan
Sarah Borden
Zachary C. Bitan
Allison Wolf
Alex Kantor
Thomas Briese
Benjamin J. Meyer
Samuel D. Jacobson
Dawn Scotto
Nischay Mishra
Neena M. Philip
Brie A. Stotler
Joseph Schwartz
Beth Shaz
Steven L. Spitalnik
Andrew Eisenberger
Eldad A. Hod
Jessica Justman
Ken Cheung
W. Ian Lipkin
Max R. O’Donnell
Publikationsdatum
17.06.2020
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04504-x

Weitere Artikel der Ausgabe 1/2020

Trials 1/2020 Zur Ausgabe